TERESA DIETZ: Open Payments
NPI 1538121991 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 34 payments from 10 companies in 2025. Trend: 2023 $324 · 2024 $185 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $267 |
| Abbott Laboratories | 4 | $78 |
| Exact Sciences Corporation | 4 | $76 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Dexcom, Inc. | 3 | $46 |
| PFIZER INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: Ozempic, Wegovy, FREESTYLE LIBRE 3, Cologuard Collection Kit, GEMTESA, XIFAXAN, Dexcom G6 Transmitter, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
